@wcmenglanderipm.bsky.social
One week from today Dr. Quaid Morris (@quaidmorris) of the Sloan Kettering Institute will present "AI for Clinical Genomics," and we hope to see you in person at Weill Greenberg Y1301 or via Zoom!
December 12, 2025 at 1:00 PM
One week from today Dr. Quaid Morris (@quaidmorris) of the Sloan Kettering Institute will present "AI for Clinical Genomics," and we hope to see you in person at Weill Greenberg Y1301 or via Zoom!
Please join us January 6th for an @WCMEnglanderIPM #PrecisionMedicine Seminar, "The Highs and Lows (-plex) of Spatial #Biology in #Autoimmune Research," by Dr. Caleb Marlin of the Oklahoma Medical Research Foundation (@OMRF)!
December 12, 2025 at 12:59 PM
Please join us January 6th for an @WCMEnglanderIPM #PrecisionMedicine Seminar, "The Highs and Lows (-plex) of Spatial #Biology in #Autoimmune Research," by Dr. Caleb Marlin of the Oklahoma Medical Research Foundation (@OMRF)!
Our next #PrecisionMedicine Seminar, "Multi-omic and Functional Landscapes of Melanoma Converge on Clinically Actionable Features," will be presented by Dr. Mitch Levesque from the University of Zürich on December 16th at noon.
Zoom only:
weillcornell.zoom.us/j/98600932819
Meeting ID: 986 0093 2819
Zoom only:
weillcornell.zoom.us/j/98600932819
Meeting ID: 986 0093 2819
December 10, 2025 at 5:43 PM
Our next #PrecisionMedicine Seminar, "Multi-omic and Functional Landscapes of Melanoma Converge on Clinically Actionable Features," will be presented by Dr. Mitch Levesque from the University of Zürich on December 16th at noon.
Zoom only:
weillcornell.zoom.us/j/98600932819
Meeting ID: 986 0093 2819
Zoom only:
weillcornell.zoom.us/j/98600932819
Meeting ID: 986 0093 2819
EIPM Member Dr. Christopher Barbieri will present a WCM Meyer Cancer Center Cancer Biology Research Program talk "Epigenetic Switches Controlling Prostate Lineage," on Dec. 12th at noon in Belfer 302-A/B.
Register today: weillcornell.az1.qualtrics.com/jfe/form/SV_...
Register today: weillcornell.az1.qualtrics.com/jfe/form/SV_...
December 8, 2025 at 1:58 PM
EIPM Member Dr. Christopher Barbieri will present a WCM Meyer Cancer Center Cancer Biology Research Program talk "Epigenetic Switches Controlling Prostate Lineage," on Dec. 12th at noon in Belfer 302-A/B.
Register today: weillcornell.az1.qualtrics.com/jfe/form/SV_...
Register today: weillcornell.az1.qualtrics.com/jfe/form/SV_...
Our Director of Ex Vivo Models Dr. Ben Hopkins is using organoids to bridge the gap between lab research and clinical care!
"Our platform is increasingly focused on identifying therapies for patients who are in need of better options."
Learn more:
eipm.weill.cornell.edu/news/bridgin...
"Our platform is increasingly focused on identifying therapies for patients who are in need of better options."
Learn more:
eipm.weill.cornell.edu/news/bridgin...
December 5, 2025 at 2:49 PM
Our Director of Ex Vivo Models Dr. Ben Hopkins is using organoids to bridge the gap between lab research and clinical care!
"Our platform is increasingly focused on identifying therapies for patients who are in need of better options."
Learn more:
eipm.weill.cornell.edu/news/bridgin...
"Our platform is increasingly focused on identifying therapies for patients who are in need of better options."
Learn more:
eipm.weill.cornell.edu/news/bridgin...
Great new paper in Blood Advances, "MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell Lymphoma," by our EIPM Directior Olivier Elemento, PhD and colleagues.
Learn more: ashpublications.org/bloodadvance...
Learn more: ashpublications.org/bloodadvance...
December 2, 2025 at 7:41 PM
Great new paper in Blood Advances, "MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell Lymphoma," by our EIPM Directior Olivier Elemento, PhD and colleagues.
Learn more: ashpublications.org/bloodadvance...
Learn more: ashpublications.org/bloodadvance...
Please join us in congratulating Dr. Andrea Sboner from the Pathology and Laboratory Medicine department and the EIPM on completing yesterday's Philadelphia Marathon--in his lucky NewYork-Presbyterian t-shirt!
November 24, 2025 at 1:27 PM
Please join us in congratulating Dr. Andrea Sboner from the Pathology and Laboratory Medicine department and the EIPM on completing yesterday's Philadelphia Marathon--in his lucky NewYork-Presbyterian t-shirt!
"Longitudinal genomic analysis of five cases of recurrent thymomas," was published in The Journal of Thoracic Oncology on November 18th by a range of EIPM colleagues!
www.jto.org/article/S155...
www.jto.org/article/S155...
Longitudinal genomic analysis of five cases of recurrent thymomas
Genomic landscape of primary thymic epithelial tumors has been explored previously.
However, the molecular alterations contributing to recurrence and potential transformation
remain largely unknown.
www.jto.org
November 21, 2025 at 3:00 PM
"Longitudinal genomic analysis of five cases of recurrent thymomas," was published in The Journal of Thoracic Oncology on November 18th by a range of EIPM colleagues!
www.jto.org/article/S155...
www.jto.org/article/S155...
Don't miss the upcoming presentation, "Applying Precision Oncology to Identify Tumor Specific Vulnerabilities in Ovarian Cancer," by our Director of Ex Vivo Models Dr. Benjamin Hopkins (@Degreesofhealth) this Friday at noon in Belfer BB 204-B!
November 19, 2025 at 7:42 PM
Don't miss the upcoming presentation, "Applying Precision Oncology to Identify Tumor Specific Vulnerabilities in Ovarian Cancer," by our Director of Ex Vivo Models Dr. Benjamin Hopkins (@Degreesofhealth) this Friday at noon in Belfer BB 204-B!
"Clinical AI’s challenge isn’t just getting deployed – it’s being used. The Epic Sepsis Model runs in hundreds of hospitals, but external validation found it missing 67% of sepsis cases while generating false alerts on 18% of patients. This pattern isn’t unique:
oncodaily.com/voices/ai-mo...
oncodaily.com/voices/ai-mo...
Olivier Elemento: Why Most Clinical AI Models Fail to Reach Real-World Practice - OncoDaily
Olivier Elemento: Why Most Clinical AI Models Fail to Reach Real-World Practice / AI model, cancer, Olivier Elemento, OncoDaily, Oncology, The Epic Sepsis Model
oncodaily.com
November 19, 2025 at 4:49 PM
"Clinical AI’s challenge isn’t just getting deployed – it’s being used. The Epic Sepsis Model runs in hundreds of hospitals, but external validation found it missing 67% of sepsis cases while generating false alerts on 18% of patients. This pattern isn’t unique:
oncodaily.com/voices/ai-mo...
oncodaily.com/voices/ai-mo...
Please join us December 16th!
November 18, 2025 at 3:44 PM
Please join us December 16th!
We hope you can join us this Friday at 11 am!
November 17, 2025 at 7:11 PM
We hope you can join us this Friday at 11 am!
Our colleague Dr. Ben Hopkins (right) leading a tour of our labs and briefing representatives from the offices of U.S. Senators, U.S. House of Representatives, N.Y. State Senator, N.Y. State Assemblymember, and NYC Council.
We enjoy explaining the research we do and why it's vitally important!
We enjoy explaining the research we do and why it's vitally important!
November 13, 2025 at 6:52 PM
Our colleague Dr. Ben Hopkins (right) leading a tour of our labs and briefing representatives from the offices of U.S. Senators, U.S. House of Representatives, N.Y. State Senator, N.Y. State Assemblymember, and NYC Council.
We enjoy explaining the research we do and why it's vitally important!
We enjoy explaining the research we do and why it's vitally important!
Congratulations Dr. Elemento!
www.webofscience.com/wos/author/r...
www.webofscience.com/wos/author/r...
November 12, 2025 at 5:39 PM
Congratulations Dr. Elemento!
www.webofscience.com/wos/author/r...
www.webofscience.com/wos/author/r...
"It is such a privilege to be part of a team and hospital that can provide this kind of exceptional care to our patients for even rare conditions (like Chiari malformation) that aren't well studied or understood,” said EIPM Member Dr. Jeffrey Greenfield.
Learn more:
people.com/chiari-malfo...
Learn more:
people.com/chiari-malfo...
4 Siblings Diagnosed with Incurable Brain Condition: 'Heartbreak I Can’t Even Describe'
Although the Higginbotham children had surgery for Chiari malformation, they're still coping with the "lasting effects."
people.com
November 6, 2025 at 10:54 PM
"It is such a privilege to be part of a team and hospital that can provide this kind of exceptional care to our patients for even rare conditions (like Chiari malformation) that aren't well studied or understood,” said EIPM Member Dr. Jeffrey Greenfield.
Learn more:
people.com/chiari-malfo...
Learn more:
people.com/chiari-malfo...
We encourage WCM clinicians, researchers & trainees to sign-up today for our bi-weekly one-hour #AI Clinic sessions to help you master advanced #AI tools like @claudeai @ChatGPTapp @XBench_Gemini and more!
www.cognitoforms.com/IPM3/AIClini...
www.cognitoforms.com/IPM3/AIClini...
November 6, 2025 at 1:25 PM
We encourage WCM clinicians, researchers & trainees to sign-up today for our bi-weekly one-hour #AI Clinic sessions to help you master advanced #AI tools like @claudeai @ChatGPTapp @XBench_Gemini and more!
www.cognitoforms.com/IPM3/AIClini...
www.cognitoforms.com/IPM3/AIClini...
Dr. Juan Miguel Mosquera and colleagues from the Pathology and Laboratory Medicine department and the Englander Institute for Precision Medicine at Weill Cornell Medicine are proud to share the acceptance of eleven (11!) abstracts at @USCAP2026! Collaborations with Isabl and BostonGene!
October 31, 2025 at 6:44 PM
Dr. Juan Miguel Mosquera and colleagues from the Pathology and Laboratory Medicine department and the Englander Institute for Precision Medicine at Weill Cornell Medicine are proud to share the acceptance of eleven (11!) abstracts at @USCAP2026! Collaborations with Isabl and BostonGene!
We hope you can join us today at noon!
October 30, 2025 at 11:37 AM
We hope you can join us today at noon!
Don't miss the new Future Oncology podcast episode, "Treatment options in hormone-sensitive prostate cancer: targeting the androgen-sensitive pathway," featuring our Clinical Director Dr. Cora N. Sternberg as special guest!
www.tandfonline.com/doi/full/10....
www.tandfonline.com/doi/full/10....
October 28, 2025 at 1:06 PM
Don't miss the new Future Oncology podcast episode, "Treatment options in hormone-sensitive prostate cancer: targeting the androgen-sensitive pathway," featuring our Clinical Director Dr. Cora N. Sternberg as special guest!
www.tandfonline.com/doi/full/10....
www.tandfonline.com/doi/full/10....
Don't miss our EIPM colleague Dr. Scott T. Tagawa's interview with @GUOncologyNow, "LuPSMA Plus ADT: Setting the Stage for Longer Benefits in mHSPC," on new metastatic hormone-sensitive prostate cancer research presented at #ESMO25.
www.guoncologynow.com/post/lupsma-...
www.guoncologynow.com/post/lupsma-...
LuPSMA Plus ADT: Setting the Stage for Longer Benefits in mHSPC | GU Oncology Now
Drs. Tagawa, Nizam continue their discussion on PSMAddition, focusing on safety outcomes and long-term implications.
www.guoncologynow.com
October 23, 2025 at 8:25 PM
Don't miss our EIPM colleague Dr. Scott T. Tagawa's interview with @GUOncologyNow, "LuPSMA Plus ADT: Setting the Stage for Longer Benefits in mHSPC," on new metastatic hormone-sensitive prostate cancer research presented at #ESMO25.
www.guoncologynow.com/post/lupsma-...
www.guoncologynow.com/post/lupsma-...
Our EIPM colleague Dr. Lisa Newman was the beneficiary of a #ShoesForACure fundraiser featured in a recent Women's Wear Daily news article timed to #BreastCancerAwarenessMonth!
wwd.com/footwear-new...
wwd.com/footwear-new...
Shoes for a Cure Kicks Off Big Week in New York With Intimate Saks Cocktail
Ahead of its five-day charity shoe sale at Chelsea Market, Shoes for a Cure hit Saks on Tuesday.
wwd.com
October 23, 2025 at 8:06 PM
Our EIPM colleague Dr. Lisa Newman was the beneficiary of a #ShoesForACure fundraiser featured in a recent Women's Wear Daily news article timed to #BreastCancerAwarenessMonth!
wwd.com/footwear-new...
wwd.com/footwear-new...
Congrats to our colleague Dr. Vivek Mittal on his new paper, "Epigenetic regulation of chromosomal instability by EZH2 methyltransferase," in Cancer Discovery with EIPM Director Olivier Elemento, PhD, and Dr. Liron Yoffe, and Bhavneet Bhinder and Marvel Tranquille!
aacrjournals.org/cancerdiscov...
aacrjournals.org/cancerdiscov...
October 23, 2025 at 4:07 PM
Congrats to our colleague Dr. Vivek Mittal on his new paper, "Epigenetic regulation of chromosomal instability by EZH2 methyltransferase," in Cancer Discovery with EIPM Director Olivier Elemento, PhD, and Dr. Liron Yoffe, and Bhavneet Bhinder and Marvel Tranquille!
aacrjournals.org/cancerdiscov...
aacrjournals.org/cancerdiscov...
“Breast cancer disparities research is essential in achieving health equity, and in identifying the root causes and optimized treatment for this disease," said Dr. Lisa Newman
(@LANewmanMD) from WCM's Dept. of Surgery and the EIPM.
#BreastCancerAwarenessMonth
swimsuit.si.com/swimnews/thi...
(@LANewmanMD) from WCM's Dept. of Surgery and the EIPM.
#BreastCancerAwarenessMonth
swimsuit.si.com/swimnews/thi...
This Breast Cancer Survivor Is Advocating for Equitable Care, Advanced Screenings
Following her diagnosis, Emily Rockefeller is advocating for making cancer screenings more routine in prenatal genetic testing.
swimsuit.si.com
October 22, 2025 at 9:18 PM
“Breast cancer disparities research is essential in achieving health equity, and in identifying the root causes and optimized treatment for this disease," said Dr. Lisa Newman
(@LANewmanMD) from WCM's Dept. of Surgery and the EIPM.
#BreastCancerAwarenessMonth
swimsuit.si.com/swimnews/thi...
(@LANewmanMD) from WCM's Dept. of Surgery and the EIPM.
#BreastCancerAwarenessMonth
swimsuit.si.com/swimnews/thi...
Congratulations to our Clinical Director Dr. Cora Sternberg for her work on "Safety and Performance of a Multi-Cancer Early Detection (#MCED) Test in an Intended Use Population: Initial Results from the #PATHFINDER 2 Study," presented at #esmo2025 Saturday!
October 20, 2025 at 1:05 PM
Congratulations to our Clinical Director Dr. Cora Sternberg for her work on "Safety and Performance of a Multi-Cancer Early Detection (#MCED) Test in an Intended Use Population: Initial Results from the #PATHFINDER 2 Study," presented at #esmo2025 Saturday!